NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary Chapter: 13 - Skin 
Notes:

Any drug not listed on the Formulary should be considered Non-Formulary - Not recommended for prescribing
Links:
British Association of Dermatology (BAD) recommended list of ’specials’ 2018
13.08.01 Sunscreen preparations

Uvistat®
(Suncream)

Amber SPA
First Choice

N.B. Must write 'ACBS' on FP10 borderline substance.

May be prescribed for skin protection against ultraviolet radiation and/or visible light in abnormal cutaneous photosensitivity causing severe cutaneous reactions in genetic disorders (including xeroderma pigmentosum and porphyrias), severe photodermatoses (both idiopathic and acquired) and in those with increased risk of ultraviolet radiation causing severe adverse effects due to chronic disease (such as haematological malignancies), medical therapies and/or procedures

 

Available as SPF 30 and 50

 

Entry reviewed: February 2023

BNF BNFc SPC

Anthelios Sunscreen Lotion SPF 50+

Amber SPA
Second Choice

For use in line with ACBS criteria only:

When prescribed for skin protection against ultraviolet radiation and/or visible light in abnormal cutaneous photosensitivity causing severe cutaneous reactions in genetic disorders (including xeroderma pigmentosum and porphyrias), severe photodermatoses (both idiopathic and acquired) and in those with increased risk of ultraviolet radiation causing adverse effects due to chronic disease (such as haematological malignancies), medical therapies and/or procedures.

 

Entry reviewed: February 2023

BNF BNFc SPC

Sunsense® Ultra
(Lotion)

Amber SPA
Second Choice

N.B. Must write 'ACBS' on FP10 borderline substance.

May be prescribed for skin protection against ultraviolet radiation and/or visible light in abnormal cutaneous photosensitivity causing severe cutaneous reactions in genetic disorders (including xeroderma pigmentosum and porphyrias), severe photodermatoses (both idiopathic and acquired) and in those with increased risk of ultraviolet radiation causing severe adverse effects due to chronic disease (such as haematological malignancies), medical therapies and/or procedures

 

Entry reviewed: February 2023

BNF BNFc SPC

5-aminolaevulinic acid (Ameluz®)
(Gel)

RED
Restricted Drug Restricted

For use with photodynamic therapy (PDT) in Dermatology

BNF BNFc SPC
Non formulary items

Borderline Substances (SpectraBan®)

 
Non Formulary
BNF BNFc SPC

Delph Sun lotion

 
Non Formulary
BNF BNFc SPC

Ultrasun sunscreen

 
Non Formulary
BNF BNFc SPC
13.08.01 Photodamage
Classifications
GREEN
May be initiated in any care setting
Amber SPA
Specialist to advise therapy and provide first 28 days supply, continuation in Primary Care
Amber SPIS
Specialist to initiate and stabilise medicine prior to continuation in Primary Care
SCG
To be prescribed as per Shared Care Guidance. If no SCG in place status reverts to red.
RED
Red medicines are designated as specialist only medicines which should only be prescribed by a specialist, usually within secondary care (either due to the requirement for specialist knowledge, long-term monitoring requirements, or restrictions that mean medicine supplies are only available to hospitals).
DNP
A decision has been made either locally and/or nationally not to routinely commission this preparation. Do not prescribe.
SELF
To be purchased over the counter. May be prescribed for chronic, long term conditions or on admission to hospital if essential.